Related Experiment Video
Updated: Mar 30, 2026

A Human Peripheral Blood Mononuclear Cell PBMC Engrafted Humanized Xenograft Model for Translational Immuno-oncology I-O Research
Published on: August 15, 2019
[Effects of Different Dose of Cyclophosphamide on Peripheral Blood Cells of Normal ICR Mice]
Guo-Lin Xiong1, Shuang Xing1, Xing Shen1
1Institute of Radiation Medicine, Academy of Military Medical Sciences, Beijing 100850, China.
Objective:
To investigate effective doses of cyclophosphamide (CTX) for establishment of leukopenia model in ICR mouse.
Methods:
Normal ICR mice (n = 96) were divided into CTX(80), CTX(100), CTX(120), CTX(150) and CTX(300) groups, of which mice received CTX intraperitoneally at a dose of 80, 100, 120, or 150 mg/kg once a day for 3 consecutive days, or 300 mg/kg with single injection. The peripheral blood cell counts were detected at various times before and after CTX administration.
Results:
The peripheral white blood cell nadirs in the mice injected with CTX appeared on day 4 after the first dose of CTX. The peripheral white blood cell nadir in group CTX(100) was 26.7% of the value measured in mice before CTX administrated, and that of group CTX(80) was 35.0%. Higher doses of CTX, however, caused too severity in hematopoietic injury.
Conclusion:
The dose of CTX 100 mg/(kg·d) × 3d is appropriate for leucopenia model of ICR mouse.
More Related Videos
08:13Rapid Quantification of Mitogen-induced Blastogenesis in T Lymphocytes for Identifying Immunomodulatory Drugs
Published on: December 27, 2016
14:26A Method to Study the Impact of Chemically-induced Ovarian Failure on Exercise Capacity and Cardiac Adaptation in Mice
Published on: April 7, 2014